MIAMI, FL / ACCESSWIRE / April 7, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. AMRN, CBAY, RXMD, and NWBO have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, NASDAQ and NYSE subscribe to our newsletter at DailyStockReporter.com.
Amarin Corporation plc (AMRN) announced earlier this week that two posters presented yesterday at the annual meeting of the American College of Cardiology. This research adds to the growing body of clinical and pre-clinical data relevant to the use of EPA with statins. Since making the announcement, shares of AMRN have increased from lows of $1.55 to highs on Thursday April 7th of $1.74 prior to 2PM EST.
Stay Informed and Up To Date On The Hottest Small Cap NASDAQ & OTC Plays. Get Them Here.
Cymabay Therapeutics, Inc. (CBAY) reported fourth quarter and annual results from 2015 recently. Research and development expense for the three and twelve months ended December 31, 2015, was $4.1 million and $17.0 million, respectively. R&D expense for the three and twelve months ended December 31, 2014 was $5.3 million and $15.8 million, respectively. The company is is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. MBX-8025 is a potent, selective, orally active PPARδ agonist. A Phase 2 study of MBX-8025 in patients with mixed dyslipidemia established that it has an anti-atherogenic lipid profile. Shares of CBAY have increased in price while also seeing above average volume with an total price jump of 38% since hitting a $1.39 close on Wednesday (4/7).
Enjoy picks like this? Get These Alerts and More on top small cap Companies before They Rally, Text the phrase "StockAlerts" to 635-66.
Progressive Care, Inc. (RXMD) announced operating results from March on April 7th. The pharmacy broke its all-time sales records during the month of March, filling approximately 18,600 prescriptions. This is over a 36% increase over the same month last year and about 1,400 more prescriptions filled compared with the Company's last highest month in September 2015. Revenues were also higher in March at close to $1.5 million, which is a 45% increase over March 2015 and nearly $100,000 more than the Company's last record breaking month in December 2015. Furthermore, it was stated that the Company is currently receiving bids from PCAOB auditing firms to conduct independent third party reviews of the quarterly and annual financial statements.
Since the beginning of the year, the stock price for RXMD is up nearly 150% with Thursday's high of $0.046. Furthermore, prices have been as high as $0.054 within the last 45 days.
Stay Informed and Up To Date On The Hottest Small Cap Stocks; Free To Join Now.
Northwest Biotherapeutics (NWBO) is a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers. The Company's lead program is a 348-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM), which is on a partial clinical hold in regard to new screening of patients. Since closing at a price of $1.57 on Wednesday, shares have increased by as much as 17% with more than 1.77 million shares traded before 2PM EST on Thursday 4/7.
Small Cap Stock Alerts: Get Them straight to your Cell Phone. To Receive Our Winning Small Cap Stock Alerts For Free, text "StockAlerts" to 63566.
www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase "StockAlerts" to 63566.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.
EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Contact Email: firstname.lastname@example.org